Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Category
Biotechnology (1524)
Antibody & Immunity (193)
Biomarker (168)
Biomaterials (56)
Biotechnology Equipment (349)
Gene Therapeutics & RNAi (104)
Genome-based Drug Discovery (204)
Molecular Targeted Therapeutics (51)
Personalized Medicine (57)
Regenerative Medicine (122)
Market Research Report

Advances in Apoptosis Research

Published by Technical Insights, Inc.
Published March, 2008 Product code 64711
Content info  
Price
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


Advances in Apoptosis Research published by Technical Insights, Inc. in March, 2008. This report price starts from US $ 6500.

Introduction

Abstract

This research service provides the latest trends in apoptosis research and future developments

Table of Contents

1 EXECUTIVE SUMMARY

  • Scope and Methodology
    • Scope of the Research Service
    • Research Methodology
  • Insights into Apoptosis
    • Apoptosis and its Relevance in Therapeutics Industry
    • Key Industry Trends in Apoptosis

2 TECHNICAL FOCUS ON APOPTOSIS PHENOMENON

  • Apoptosis Molecular Pathways Exploration
    • Key Categories of Molecular Pathway Proteins
    • Understanding the Role of Apoptosis Proteins
  • Apoptosis Correlated Therapeutic fields
    • Apoptosis Functioning in Cancer Treatment
    • Apoptosis Basis Connected with Neurodegenerative and Cardiovascular Diseases
  • Other Cell Apoptosis-Centered Disorders
    • Organ Transplantation-Associated Syndromes
    • HIV and Cell Sepsis Controlled by Apoptosis
  • Apoptosis Identification Techniques
    • Diagnosis and Analyzing Apoptosis In Vivo
    • Potential Markers for Apoptosis Recognition

3 ASSESSMENT OF NOTABLE TECHNOLOGIES INVOLVED IN DRUG DISCOVERY FOR APOPTOSIS-BASED TREATMENT

  • Highlights of Key Developments in the North American region.
    • Triggering Apoptosis:Innovative Oncology Drug Discovery Platform
    • Broad Range of Clinical Development Compounds for the Treatment of Advanced Solid Tumors
    • Promising Small Molecule Investigational Drugs Targeting Malignancies
    • Novel Cancer Therapies Targeting Treatment Resistance in Oncology Patients
    • Tumor-Targeting Antibodies Delivering Potent Cell-Killing Agents
    • Cell Cycle Inhibitors Work on Cancer through Apoptosis
    • Medical Device Employs Apoptosis to Reduce Cardiac Inflammation
    • BCL-2 Emerges as a Hot Target for Cancer Therapeutics
  • Notable Developments in the Rest of the World
    • Unique Anticancer Therapeutics Targeting Cell Death Pathways
    • Novel Small Molecules Product Targeting Established Tumor Blood Vessels
    • Potential Treatment Paradigm Designed for the Treatment of Solid Tumors
    • Pioneering Oligonucleotide-Based Drugs Targeting Malignant Tumors
    • Promising Drug Development Platform with Broad Oncology Applications
    • Advancements in Progressive Functional Pathways Studies Critical to Cancer Cells Growth
    • Novel Class of Clinical-Stage Tumor Growth-Reducing Cancer Therapeutics
    • Novel Drug Therapy for Treating Solid Tumors and Blood Cancer
    • Highly Targeted and Potent Antiangiogenic Cancer Therapy
  • Universities Advancements
    • Miniature Stage Biomarker-Focused Translational Research
    • Novel Research Findings Identifying Combination Therapy for Cancer
    • Innovative Research Findings Exploiting Oncolytic Virus Therapy for Cancer Treatment

4 TECHNOLOGY ADOPTION FACTOR ANALYSIS

  • Drivers and Challenges Involved in Apoptosis Treatment
    • Notable Drivers
    • Challenges and Restraints
  • Patent Assessment and Analyst Insights
    • Patent Assessment
    • Analyst' s Perspective and Futuristic Trends
    • Entry and Expansion Strategies

5 PATENT STUDY AND DATABASE OF KEY PARTICIPANTS.

  • Patents Review
    • Corporate Patents
    • Academic Patents
  • Main Participants
    • Companies
    • Universities

6 DECISION SUPPORT DATABASE

  • Database Tables
    • World R&D Expenditure
    • World Healthcare Expenditure (2002 to 2012)
    • Mortality of Bladder Cancer--World (2002 to 2012)
    • Incidence of Bladder Cancer--World (2002 to 2012)
    • Number of Active Physicians (2002 to 2012)
Back to Top